This variability could stem from differences in the functions of AURKA and its downstream targets in various tumor types, akin to other genes such as DKK1 and Fam20C, which exhibit varying prognostic implications in different cancer types within pan-cancer studies (34, 35). This evidence concerns the gene DKK1 and neoplasm.